Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Nebulised bronchodilators, antibiotics and rhDNase for children with cystic fibrosis.

× No keyword cloud information.

15 in total

1. Tracheal mucociliary transport in patients with cystic fibrosis and its stimulation by terbutaline.

Authors: R E Wood; A Wanner; J Hirsch; P M Farrell
Journal: Am Rev Respir Dis Date: 1975-06

Review 2. Immunology of cystic fibrosis.

Authors: J O Warner
Journal: Br Med Bull Date: 1992-10 Impact factor: 4.291

3. The variable effect of a bronchodilating agent on pulmonary function in cystic fibrosis.

Authors: L I Landau; P D Phelan
Journal: J Pediatr Date: 1973-05 Impact factor: 4.406

4. Prevention of chronic Pseudomonas aeruginosa colonisation in cystic fibrosis by early treatment.

Authors: N H Valerius; C Koch; N Høiby
Journal: Lancet Date: 1991-09-21 Impact factor: 79.321

Review 5. Inhaled therapy in paediatrics.

Authors: P D Sly; P N Le Souëf
Journal: J Paediatr Child Health Date: 1991-02 Impact factor: 1.954

6. How to get drugs into the respiratory tract.

Authors: C O'Callaghan
Journal: Arch Dis Child Date: 1993-04 Impact factor: 3.791

7. The effect of high doses of inhaled salbutamol and ipratropium bromide in patients with stable cystic fibrosis.

Authors: I Sanchez; J De Koster; J Holbrow; V Chernick
Journal: Chest Date: 1993-09 Impact factor: 9.410

8. Prediction of mortality in patients with cystic fibrosis.

Authors: E Kerem; J Reisman; M Corey; G J Canny; H Levison
Journal: N Engl J Med Date: 1992-04-30 Impact factor: 91.245

9. Pseudomonas aeruginosa infection in cystic fibrosis. Diagnostic and prognostic significance of Pseudomonas aeruginosa precipitins determined by means of crossed immunoelectrophoresis.

Authors: N Hoiby; E W Flensborg; B Beck; B Friis; S V Jacobsen; L Jacobsen
Journal: Scand J Respir Dis Date: 1977-04

10. Efficacy and safety of short-term administration of aerosolized recombinant human deoxyribonuclease in patients with cystic fibrosis.

Authors: B W Ramsey; S J Astley; M L Aitken; W Burke; A A Colin; H L Dorkin; J D Eisenberg; R L Gibson; I R Harwood; D V Schidlow
Journal: Am Rev Respir Dis Date: 1993-07

4 in total

Review 1. Asthma in cystic fibrosis.

Authors: Ian M Balfour-Lynn
Journal: J R Soc Med Date: 2003 Impact factor: 5.344

Nebulised bronchodilators, antibiotics and rhDNase for children with cystic fibrosis.